This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: Society affairs & governance

EAS Joint session at ESC Amsterdam - see you there

Friday 27 March 2020  
Posted by: Carmel Hayes
Share |

From Lifetime Risk to Real Life: Decreasing Cardiovascular Risk with Lipid Lowering

Joint between the European Atherosclerosis Society (EAS) and European Society of Cardiology (ESC)

EAS traditionally take part at the ESC annual Congress with a joint session, and this year is no exception. We very much appreciate this opportunity to connect with cardiologists from around the world. The programme that will be presented this year looks at how CV risk is affected by lipid lowering, and what that means for management of patients. 

Chairpersons: Lale Tokgozoglu (Ankara, TR) - Francois Mach (Geneva, CH)

  • Atherogenic lipoproteins from newborn to adulthood - Impact on lifetime risk.
    Ruth Frikke-Schmidt (Copenhagen, DK)
  • Da Vinci Study: what have we learnt from 18 European countries on lipid management?
    Kausik K Ray (London, GB)
  • Safety of very low LDL cholesterol levels.
    Marc Sabatine (Boston,US)
  • Should we lower triglycerides?
    Jane Armitage (Oxford,GB)

Congress of the European Society of Cardiology, ESC 2020, Amsterdam.

  • Monday, 31 August 2020 11:00 - 12:30 Skopje - Village 2
  • Session Number: 723 

Membership Software Powered by YourMembership  ::  Legal